You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Basosquamous

Showing 1 - 25 of 7,642
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting
  • Adenoid Cystic Skin Carcinoma
  • +38 more
  • Biopsy
  • +6 more
  • Los Angeles, California
  • +35 more
Jan 31, 2023

Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

Recruiting
  • Squamous Cell Carcinoma of Oral Cavity
  • +3 more
  • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
  • Gliwice, Silesia, Poland
    The Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Atezolizumab, Bevacizumab, HAIC with FOLFOX)

Recruiting
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 24, 2023

Squamous Cell Carcinoma of Head and Neck, Basal Cell Carcinoma of Skin Trial in Vandœuvre-lès-Nancy (microscopy confocal

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Basal Cell Carcinoma of Skin
  • microscopy confocal (Histolog Scanner)
  • Vandœuvre-lès-Nancy, France
    Gilles Dolivet
Jul 7, 2023

Urologic Cancer Trial in Taipei

Recruiting
  • Urologic Cancer
    • Taipei, Taiwan
      Yu wei-lan
    Feb 2, 2023

    Hepatocellular Carcinoma Trial in Hangzhou (PVE+cTACE+Camrelizumab+Apatinib, cTACE+Atirizumab+Bevacizumab)

    Recruiting
    • Hepatocellular Carcinoma
    • PVE+cTACE+Camrelizumab+Apatinib
    • cTACE+Atirizumab+Bevacizumab
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Feb 26, 2023

    The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

    Recruiting
    • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
    • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
    • Hanzhou, Zhejiang, China
      Lulu Liu
    Jul 14, 2023

    Endometrial Carcinoma, Tumor Molecular Features Screening Model Trial (open surgery, laparoscopic surgery)

    Not yet recruiting
    • Endometrial Carcinoma
    • Tumor Molecular Features Screening Model
    • open surgery
    • laparoscopic surgery
    • (no location specified)
    Jun 7, 2023

    Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)

    Not yet recruiting
    • Squamous Cell Carcinoma of the Skin
    • Carrilizumab with albumin-binding paclitaxel
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    May 23, 2023

    Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • KSD-101
    • Wuhan, China
      Tongji Hospital, Tongji Medical College, Huazhong University of
    Oct 19, 2023

    Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Recruiting
    • Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jun 5, 2023

    Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
    • (no location specified)
    Mar 17, 2023

    Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

    Recruiting
    • Metastatic Esophageal Squamous Cell Carcinoma
    • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
    • Qingdao, Shandong, China
    • +1 more
    Nov 13, 2023

    Simultaneous CLE Guided Crybiopsy in Pulmonary Nodules

    Recruiting
    • Pulmonary Disease
    • CLE-guided cryobiopsy
    • Vienna, Austria
      Medical University of Vienna
    Sep 20, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 17, 2023

    Solid Tumors Trial in Worldwide (Avelumab)

    Completed
    Has Results
    • Solid Tumors
    • Goodyear, Arizona
    • +73 more
    Oct 26, 2021

    Key Genes in Hepatocellular Carcinoma

    Recruiting
    • Hepatocellular Carcinoma
    • None of intervention
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Feb 26, 2023

    Single-cell RNA Sequencing Resolves Regulatory Role of HBV on

    Recruiting
    • HBV
    • Primary Liver Cancer
    • HBV DNA Sequencing
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Dec 22, 2022

    Nasopharyngeal Carcinoma Screening Based on Tongue Imaging

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Tongue image
    • Zhuhai, China
      The Fifth Affiliated Hospital of Sun Yat sen University
    Nov 10, 2023

    Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Head and Neck Squamous Cell Carcinoma
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Oct 25, 2023

    Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

    Not yet recruiting
    • Squamous Cell Carcinoma
      • San Francisco, California
        Power Life Sciences
      Jun 23, 2023

      Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Orlando (Exercise Test)

      Not yet recruiting
      • Cutaneous Melanoma
      • +2 more
      • Exercise Test
      • Orlando, Florida
        AdventHealth Translational Research Institute
      Aug 18, 2023

      Hepatocellular Carcinoma Trial in Seoul (Lenvatinib)

      Recruiting
      • Hepatocellular Carcinoma
      • Seoul, Korea, Republic of
        Asan Medical Center
      Nov 14, 2023

      Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)

      Recruiting
      • Locally Advanced or Metastatic Solid Tumors
      • +10 more
      • Aurora, Colorado
      • +6 more
      Jan 4, 2023

      Immunotherapy in Upper Tract Urothelial Carcinoma

      Not yet recruiting
      • Urothelial Carcinoma
      • Evaluation of anti-PD-(L)1 immunotherapy efficacy
      • (no location specified)
      Oct 27, 2023